Also known as: Blood transfusion reaction
- Back pain
- [[1003138|Bloody urine]]
- [[1003092|Fainting]] or [[1003093|dizziness]]
- [[1003113|Flank pain]]
- Flushing of the skin
- [[1003344|Coombs' test, direct]]
- Coombs' test, indirect
- [[1003655|Fibrin degradation products]]
- [[1003653|Partial thromboplastin time]]
- [[1003652|Prothrombin time]]
- [[1003479|Serum bilirubin]]
- [[1003475|Serum creatinine]]
- [[1003677|Serum hemoglobin]]
- Urine hemoglobin
- Acetaminophen, a pain reliever to reduce fever and discomfort
- Fluids given through a vein (intravenous) and other medicines to treat or prevent kidney failure and shock.
- [[1000501|Acute kidney failure]]
- Lung problems
A hemolytic transfusion reaction is a serious complication that can occur after a transfusion of blood. The red blood cells that were given in the transfusion are destroyed by the patient's immune system.
There are other types of allergic transfusion reactions that do not cause hemolysis.
Blood is classified into different blood types called A, B, AB, and O.
Your immune system can usually tell its own blood cells from blood cells from those of another person. If other blood cells enter your body, your immune system may already have antibodies against them. These antibodies will work to destroy the blood cells that your immune system does not recognize.
Another way blood cells may be classified is by Rh factors. People who have Rh factors in their blood are called "Rh positive." People without these factors are called "Rh negative." Rh negative people form antibodies against Rh factor if they receive Rh positive blood.
There are also other factors to identify blood cells, in addition to ABO and Rh.
Blood that you receive in a transfusion must be compatible with your own blood. This means that your body does not have antibodies against the blood you receive.
Most of the time, blood transfusion between compatible groups (such as O+ to O+) does not cause a problem. Blood transfusion between incompatible groups (such as A+ to O-) causes an immune response. This can lead to a serious transfusion reaction. The immune system attacks the donated blood cells, causing them to burst.
Today, all blood is carefully screened. Transfusion reactions very rare.
Symptoms of a hemolytic transfusion reaction most often appear during or right after the transfusion. Sometimes, they may develop after several days (delayed reaction).
Exams and Tests
This disease may change the results of these tests:
Therapy can prevent or treat the severe effects of a hemolytic transfusion reaction. If symptoms occur during the transfusion, the transfusion must be stopped immediately. Blood samples from the person getting the transfusion and from the donor may be tested to tell whether symptoms are being caused by a transfusion reaction.
Mild symptoms may be treated with:
The outcome depends on how bad the reaction is. The disorder may disappear without problems. Or, it may be severe and life-threatening.
When to Contact a Medical Professional
Tell your health care provider if you are having a blood transfusion and you have had a reaction before.
Donated blood is put into ABO and Rh groups to reduce the risk of transfusion reaction.
Before a transfusion, patient and donor blood are tested (crossmatched) to see if they are compatible with each other. A small amount of donor blood is mixed with a small amount of patient blood. The mixture is checked under a microscope for signs of antibody reaction.
Before the transfusion is given, the health care provider will usually check again to make sure you are receiving the right unit of blood.
Choat JD, Maitta RW, Tormey CA, et al. Transfusion reactions to blood and cell therapy products. In: Hoffman R, Benz EJ Jr, Silberstein LE, Heslop HE, Weitz JI, eds. Hematology: Basic Principles and Practice. 6th ed. Philadelphia, PA: Saunders Elsevier; 2012:chap 120.
Goodnough L. Transfusion medicine. In: Goldman L, Schafer AI, eds. Goldman's Cecil Medicine. 24th ed. Philadelphia, PA: Saunders Elsevier; 2011:chap 180.
- Review date:
- March 3, 2013
- Reviewed by:
- Yi-Bin Chen, MD, Leukemia/Bone Marrow Transplant Program, Massachusetts General Hospital. Also reviewed by A.D.A.M. Health Solutions, Ebix, Inc., Editorial Team: David Zieve, MD, MHA, Bethanne Black, Stephanie Slon, and Nissi Wang.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2008 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.